← Back to headlines
Guggenheim Maintains Investment Ratings on Summit Therapeutics and Dick’s Sporting Goods
Guggenheim Securities has reaffirmed its investment ratings for both Summit Therapeutics and Dick’s Sporting Goods, citing recent clinical trial developments and standard market evaluations.
26 Aug, 11:58 — 26 Aug, 11:58
Sources
Showing 1 of 1 sources
Related Stories
US and Iran Resume Direct Military Strikes as Oil Prices Surge
17m ago
US Treasury Secretary Urges Bank of Japan to Maintain Sound Monetary Policy Amid Yen Volatility
2h ago
Apple Sets Executive Pay for New CEO John Ternus and Chair Tim Cook
2h ago
BOJ to debate rate rise, inflation much closer to 2% target: governor
2h ago